Loading...
•
Jun 30, 2023
Natera Q2 2023 Earnings Report
Reported strong Q2 2023 results with revenue growth and improved gross margin.
Key Takeaways
Natera reported a strong second quarter with a 31.9% increase in total revenues, driven by a 32.7% increase in product revenues. The company processed approximately 617,200 tests and reported a net loss of $110.8 million, an improvement compared to the previous year. Natera is raising its full year revenue guidance.
Served over 600,000 patients in Q2 2023.
Delivered significant year-over-year growth in volumes and revenues.
Improved gross margin.
Reduced quarterly cash burn.
Forward Guidance
Natera is raising its expectations for 2023 total revenue from $995 million to $1.015 billion to a new range of $1.015 billion to $1.035 billion. The Company expects 2023 gross margin to be approximately 41% to 44% of revenues; selling, general and administrative costs to be approximately $540 million to $580 million; research and development costs to be approximately $325 million to $345 million; and net cash consumption to be approximately $300 million to $325 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...